Volume 30, Number 3—March 2024
Research
Systematic Review of Scales for Measuring Infectious Disease–Related Stigma
Table 3
Action-oriented stigma domains† | Experiential stigma domains |
||
---|---|---|---|
Prejudice‡ | Discrimination§ | Medically unwarranted avoidance¶ | |
Social: stigmatization by friends and family |
“I feel blamed by relatives or friends,” Self-stigma Scale (SSS-15) |
“[I was] forced to change residence because of social alienation,” 7-item EVD-related stigma index |
“People I cared for stopped calling or interacting after learning that I was infected/suspected,” COVID-19 Stigma Scale |
Public: stigmatization by broader community and strangers |
“Most people think that a person who has had Ebola is disgusting,” Ebola/COVID-19–related Stigma Survey |
“I have been insulted/discriminated because of my history of being infected/suspected,” COVID-19 Stigma Scale |
“Some people avoid touching me even after my recovery once they knew I was infected with/suspected,” COVID-19 stigma scale |
Workplace: stigmatization by colleagues and employers |
“My feeling of job security has been affected by my illness,” COVID-19 Perceived Stigma Scale-22 (CPSS-22) |
“I will dismiss my employee who recovers from COVID-19,” Social stigma and discriminatory attitudes scale |
“Someone refused to buy products from you,” Stigmatization related to EVD and COVID-19 scale |
Provider-related: stigmatization by service providers |
“You feel it is not worthwhile for you to serve persons who contracted COVID-19” - Stigma Discrimination Scale (SDS-11) |
“[I was] treated unfairly by healthcare professionals,” COVID-19 Experienced DISCrimination Scale (CEDISC) |
“I was denied health care services when the doctors found out I was infected /suspected,” COVID-19 Stigma Scale |
Structural: stigmatization by institutions |
NA |
“The first COVID-19 patient in each city should be identified and penalised due to their role in spreading the disease,” COVID-19-related enacted Stigma Questionnaire |
“At the hospital/clinic, I was made to wait until the last,” Ebola-related stigma instrument |
Self: internalization of stigma | “Having had COVID-19 infection makes me feel that I am a bad person,” COVID-19-related Stigma Survey | “I stopped eating with other people,” Ebola-related stigma instrument | NA |
Anticipated; disclosure concerns or avoidance due to fear of stigma |
“I worry that people may judge me negatively when they find out I have long Covid,” Long COVID Stigma Scale (LCSS) |
“You have avoidance behaviours such as staying home for fear of being stigmatised or rejected,” Stigmatization related to EVD and COVID-19 scale |
NA |
Stigma-by-association; stigmatization of those societally associated with the disease or infected persons but not personally infected | “If they knew about it would your neighbors, colleagues or others in your community think less of your family because of your COVID-19 infection?” Arabic Explanatory Model Interview Catalogue (EMIC) | “A school refused to accept your children,” Stigmatization related to EVD and COVID-19 scale | “If a person was infected with COVID-19, it is better to avoid his/her family members,” Community COVID-19 Stigma Scale |
*Framework based on stigma typology from Jones and Corrigan (6). EVD, Ebola virus disease; NA, not applicable. †Domains adopted from Pescosolido and Martin (27). ‡Negative thoughts and feelings toward stigmatized persons. §Enactment of prejudice or differential treatment of stigmatized persons. ¶Neglect of stigmatized persons.
References
- Cénat JM, Rousseau C, Bukaka J, Dalexis RD, Guerrier M. Severe anxiety and PTSD symptoms among Ebola virus disease survivors and healthcare workers in the context of the COVID-19 pandemic in Eastern DR Congo. Front Psychiatry. 2022;13:
767656 . DOIPubMedGoogle Scholar - Gregorio ER Jr, Medina JRC, Lomboy MFTC, Talaga ADP, Hernandez PMR, Kodama M, et al. Knowledge, attitudes, and practices of public secondary school teachers on Zika Virus Disease: A basis for the development of evidence-based Zika educational materials for schools in the Philippines. PLoS One. 2019;14:
e0214515 . DOIPubMedGoogle Scholar - Lee S, Chan LY, Chau AM, Kwok KP, Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Soc Sci Med. 2005;61:2038–46. DOIPubMedGoogle Scholar
- Usifoh SF, Odigie AE, Ighedosa SU, Uwagie-Ero EA, Aighewi IT. Lassa fever-associated stigmatization among staff and students of the University of Benin, Nigeria. J Epidemiol Glob Health. 2019;9:107–15. DOIPubMedGoogle Scholar
- Goffman E. Stigma: notes on the management of spoiled identity. New York: J. Aronson; 1974.
- Jones N, Corrigan PW. Understanding stigma. In: Corrigan PW, editor. The stigma of disease and disability. Understanding causes and overcoming injustices. Washington: American Psychological Association; 2014. p. 9–34.
- Weiss MG. Stigma and the social burden of neglected tropical diseases. PLoS Negl Trop Dis. 2008;2:
e237 . DOIPubMedGoogle Scholar - Stangl AL, Earnshaw VA, Logie CH, van Brakel W, C Simbayi L, Barré I, et al. The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17:31. DOIPubMedGoogle Scholar
- Major B, Dovidio JF, Link BG, Calabrese SK. Stigma and its implications for health: introduction and overview. In: Major B, Dovidio JF, Link BG, editors. The Oxford handbook of stigma, discrimination, and health. New York: Oxford University Press; 2018. p. 3–28.
- Trinh DH, McKinn S, Nguyen AT, Fox GJ, Nguyen AT, Bernays S. Uneven stigma loads: Community interpretations of public health policies, ‘evidence’ and inequities in shaping Covid-19 stigma in Vietnam. SSM Popul Health. 2022;20:
101270 . DOIPubMedGoogle Scholar - Van Brakel WH. Measuring health-related stigma—a literature review. Psychol Health Med. 2006;11:307–34. DOIPubMedGoogle Scholar
- Cénat JM, Noorishad PG, Kokou-Kpolou CK, Dalexis RD, Hajizadeh S, Guerrier M, et al. Prevalence and correlates of depression during the COVID-19 pandemic and the major role of stigmatization in low- and middle-income countries: A multinational cross-sectional study. Psychiatry Res. 2021;297:
113714 . DOIPubMedGoogle Scholar - Cénat JM, Noorishad PG, Dalexis RD, Rousseau C, Derivois D, Kokou-Kpolou CK, et al. Prevalence and risk factors of depression symptoms among rural and urban populations affected by Ebola virus disease in the Democratic Republic of the Congo: a representative cross-sectional study. BMJ Open. 2022;12:
e053375 . DOIPubMedGoogle Scholar - Nyblade L, Stockton MA, Giger K, Bond V, Ekstrand ML, Lean RM, et al. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019;17:25. DOIPubMedGoogle Scholar
- Rajkumar E, Rajan AM, Daniel M, Lakshmi R, John R, George AJ, et al. The psychological impact of quarantine due to COVID-19: A systematic review of risk, protective factors and interventions using socio-ecological model framework. Heliyon. 2022;8:
e09765 . DOIPubMedGoogle Scholar - Li L, Wang J, Leng A, Nicholas S, Maitland E, Liu R. Will COVID-19 vaccinations end discrimination against COVID-19 patients in China? New evidence on recovered COVID-19 patients. Vaccines (Basel). 2021;9:490. DOIPubMedGoogle Scholar
- Mazzagatti R, Riva MA. Monkeypox vaccine-related stigma. Public Health Pract (Oxf). 2022;4:
100336 . DOIPubMedGoogle Scholar - Logie CH. What can we learn from HIV, COVID-19 and mpox stigma to guide stigma-informed pandemic preparedness? J Int AIDS Soc. 2022;25:
e26042 . DOIPubMedGoogle Scholar - Kwon PhD S. Mask wearing and perceived discrimination associated with COVID-19 in the United States from March 2020 to May 2021: three-level longitudinal analyses. Health Educ Behav. 2022;49:200–9. DOIPubMedGoogle Scholar
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. DOIPubMedGoogle Scholar
- Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27:1147–57. DOIPubMedGoogle Scholar
- Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am J Ment Defic. 1981;86:127–37.PubMedGoogle Scholar
- Stevelink SAM, van Brakel WH. The cross-cultural equivalence of participation instruments: a systematic review. Disabil Rehabil. 2013;35:1256–68. DOIPubMedGoogle Scholar
- Carroll C, Booth A, Leaviss J, Rick J. “Best fit” framework synthesis: refining the method. BMC Med Res Methodol. 2013;13:37. DOIPubMedGoogle Scholar
- Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27:1171–9. DOIPubMedGoogle Scholar
- Pantelic M, Ziauddeen N, Boyes M, O’Hara ME, Hastie C, Alwan NA. Long Covid stigma: Estimating burden and validating scale in a UK-based sample. PLoS One. 2022;17:
e0277317 . DOIPubMedGoogle Scholar - Pescosolido BA, Martin JK. The stigma complex. Annu Rev Sociol. 2015;41:87–116. DOIPubMedGoogle Scholar
- Alchawa M, Naja S, Ali K, Kehyayan V, Haddad PM, Bougmiza I. COVID-19 perceived stigma among survivors: A cross-sectional study of prevalence and predictors. Eur J Psychiatry. 2023;37:24–35. DOIPubMedGoogle Scholar
- Mlouki I, Zammit N, Ghammem R, Ben Fredj S, Bannour R, El Echi A, et al. Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID-19 patients after quarantine: A cross-sectional study. Health Sci Rep. 2022;5:
e520 . DOIPubMedGoogle Scholar - Nair S, Joshi A, Aggarwal S, Adhikari T, Mahajan N, Diwan V, et al. Development & validation of scales to assess stigma related to COVID-19 in India. Indian J Med Res. 2022;155:156–64. DOIPubMedGoogle Scholar
- Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018;6:149. DOIPubMedGoogle Scholar
- Dar SA, Khurshid SQ, Wani ZA, Khanam A, Haq I, Shah NN, et al. Stigma in coronavirus disease-19 survivors in Kashmir, India: A cross-sectional exploratory study. PLoS One. 2020;15:
e0240152 . DOIPubMedGoogle Scholar - Kibria MG, Islam T, Islam MT, Kabir R, Ahmed S, Sultana P. Stigma and its associated factors among patients with COVID-19 in Dhaka City: evidence from a cross-sectional investigation. PeerJ. 2022;10:
e14092 . DOIPubMedGoogle Scholar - Overholt L, Wohl DA, Fischer WA II, Westreich D, Tozay S, Reeves E, et al. Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study. PLoS One. 2018;13:
e0206595 . DOIPubMedGoogle Scholar - Mokkink LB, Prinsen CA, Patrick DL, Alonso J, Bouter LM, de Vet HCW, et al. COSMIN study design checklist for patient-reported outcome measurement instruments 2019 [cited 2023 Nov 3] https://www.cosmin.nl/wp-content/uploads/COSMIN-study-designing-checklist_final.pdf
- Li T, Bu H, Duan W. A brief measure of perceived courtesy and affiliate stigma on COVID-19: A study with a sample from China. Pers Individ Dif. 2021;180:
110993 . DOIPubMedGoogle Scholar - Al-Zamel LA, Al-Thunayan SF, Al-Rasheed AA, Alkathiri MA, Alamri F, Alqahtani F, et al. Validation and cultural adaptation of Explanatory Model Interview Catalogue (EMIC) in assessing stigma among recovered patients with COVID-19 in Saudi Arabia. Int J Environ Res Public Health. 2021;18:8261. DOIPubMedGoogle Scholar
- Stangl AL, Lilleston P, Mathema H, Pliakas T, Krishnaratne S, Sievwright K, et al.; HPTN 071 (PopART) Study Team. Development of parallel measures to assess HIV stigma and discrimination among people living with HIV, community members and health workers in the HPTN 071 (PopART) trial in Zambia and South Africa. J Int AIDS Soc. 2019;22:
e25421 . DOIPubMedGoogle Scholar - Sigfrid L, Maskell K, Bannister PG, Ismail SA, Collinson S, Regmi S, et al. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review. BMC Med. 2020;18:190. DOIPubMedGoogle Scholar
- World Health Organization. Prioritizing diseases for research and development in emergency contexts [cited 2023 Nov 3]. https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts
Page created: December 31, 2023
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.